Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
Finished Drug Prices
NA
1. 1-(4-cyanophenyl)-4-(1-methylprop-2-enyl)-tbo
2. Cyano-tbo
1. 135097-63-1
2. Cyano-tbo
3. 1-(4-cyanophenyl)-4-(1-methylprop-2-enyl)-tbo
4. Dtxsid70928883
5. 4-(4-but-3-en-2-yl-2,6,7-trioxabicyclo[2.2.2]octan-1-yl)benzonitrile
6. 1-[4-(1-methyl-2-propenyl)-2,6,7-trioxabicyclo[2.2.2]octan-1-yl]-4-cyanobenzene
7. 4-[4-(but-3-en-2-yl)-2,6,7-trioxabicyclo[2.2.2]octan-1-yl]benzonitrile
8. Benzonitrile, 4-(4-(1-methyl-2-propenyl)-2,6,7-trioxabicyclo(2.2.2)oct-1-yl)-
Molecular Weight | 271.31 g/mol |
---|---|
Molecular Formula | C16H17NO3 |
XLogP3 | 2.1 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 3 |
Exact Mass | 271.12084340 g/mol |
Monoisotopic Mass | 271.12084340 g/mol |
Topological Polar Surface Area | 51.5 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 406 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Global Sales Information
ABOUT THIS PAGE
A Tbo-Filgrastim manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tbo-Filgrastim, including repackagers and relabelers. The FDA regulates Tbo-Filgrastim manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tbo-Filgrastim API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tbo-Filgrastim supplier is an individual or a company that provides Tbo-Filgrastim active pharmaceutical ingredient (API) or Tbo-Filgrastim finished formulations upon request. The Tbo-Filgrastim suppliers may include Tbo-Filgrastim API manufacturers, exporters, distributors and traders.
Tbo-Filgrastim Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tbo-Filgrastim GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tbo-Filgrastim GMP manufacturer or Tbo-Filgrastim GMP API supplier for your needs.
A Tbo-Filgrastim CoA (Certificate of Analysis) is a formal document that attests to Tbo-Filgrastim's compliance with Tbo-Filgrastim specifications and serves as a tool for batch-level quality control.
Tbo-Filgrastim CoA mostly includes findings from lab analyses of a specific batch. For each Tbo-Filgrastim CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tbo-Filgrastim may be tested according to a variety of international standards, such as European Pharmacopoeia (Tbo-Filgrastim EP), Tbo-Filgrastim JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tbo-Filgrastim USP).
LOOKING FOR A SUPPLIER?